Fidelis Insurance Group Presentation
Investor Presentation
Safe Harbor Statement
Cautionary Note Regarding Forward-Looking Statements
This document (including the documents incorporated herein) contains, and our officers and representatives may from time to time make (including on our related conference call), "forward-looking statements" which include all statements that do not relate solely to historical or current facts and which may conceour strategy, plans, projections or intentions and are made pursuant to the safe harbor provisions of the
Examples of forward-looking statements include, among others, statements we make in relation to: discussion relating to net income and net income per share; expected operating results, such as revenue growth and earnings; our expectations regarding our strategy and the performance of our business; information regarding our estimates for catastrophes and other loss events; our liquidity and capital resources; and expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings.
Our actual results in the future could differ materially from those anticipated in any forward-looking statements as a result of changes in assumptions, risks, uncertainties and other factors impacting us, many of which are outside our control, including: the ongoing trend of premium rate hardening and factors likely to drive continued rate hardening; expected growth across our portfolio; the availability of outwards reinsurance and capital resources as required; the development and patteof earned and written premiums impacting embedded premium value; changes in accounting principles or the application thereof; the level of underwriting leverage; the level and timing of catastrophe and other losses and related reserves on the business we underwrite; the performance of our investment portfolios; our strategic relationship with
Any forward-looking statements, expectations, beliefs and projections made by us in this release and on our related conference call speak only as of the date on which they are made and are expressed in good faith and our management believes that there is reasonable basis for them, based only on information currently available to us. However, there can be no assurance that management's expectations, beliefs, and projections will be achieved and actual results may vary materially from what is expressed or indicated by the forward-looking statements. Furthermore, our past performance, and that of our management team and of
RPI Measure
Renewal price index (RPI) is a measure that Fidelis has used to assess an approximate index of rate increases on a particular set of contracts, using the base of 100% for the rates for the relevant prior year. Although management considers RPI to be an appropriate statistical measure, it is not a financial measure that directly relates to the Fidelis consolidated financial results. Management's calculation of RPI involves a degree of judgment in relation to comparability of contracts and the relative impacts of changes in price, exposure, retention levels, as well as any other changing terms and conditions on the RPI calculation. Consideration is given to potential renewals of a comparable nature so it does not reflect every contract in Fidelis' portfolio. The future profitability and performance of a portfolio of contracts expressed within the RPI is dependent upon many factors besides the trends in premium rates, including policy terms, conditions and wording.
2
A leading global specialty insurer, leveraging strategic partnerships to offer innovative and tailored insurance solutions
Highlights
"FIHL" Shares Listed on the
2023
18.8%
Most Recent FY
Operating ROAE(2)
Total Assets(1)
Market
Capitalization(1)
Current Quarterly
Dividend and Annual
Yield(1)
Cash & Invested
Assets (1)
Business Mix by Gross Premiums Written(3)
|
19% |
||||
|
63% |
||||
|
Bespoke |
||||
|
Specialty |
|
|||
Billion
18%
Reinsurance
|
|
Diverse portfolio of over 100 products across |
|
our three segments |
|
|
|
Well-positioned to benefit from sustained hard |
|
market conditions |
|
|
|
Shorter-tail lines with optimized natural |
|
catastrophe exposure and no casualty exposure |
|
A |
A- |
A3 |
|
AM Best(4) |
S&P(4) |
Moody's(4) |
|
Stable Outlook |
Stable Outlook |
Stable Outlook |
|
Leveraging strategic relationships and nimble |
|
underwriting to drive market-leading loss ratios |
|
Note: |
|
|
(1) Results for the quarter ended |
|
|
as operating net income divided by adjusted average common shareholders' equity. See Important Notice and Appendix for reconciliation. (3) Business mix based on Gross Premiums Written trailing |
3 |
|
twelve months ("TTM") as of |
Profitable Underwriting
- Be recognized as a thought leader and global leader in specialty insurance
- Serve as lead underwriter across business lines
- Consistently generate industry leading combined ratio
- Maintain flexibility to manage through the cycle with less volatility
Efficient Operations
- Further invest in internal functionality to strengthen position as the provider of choice
- Sustain strong alignment with our strategic partners to ensure the delivery of a diversified portfolio across our targeted classes of business
- Commitment to actively manage capital through the cycle to support profitable growth
- Maintain appropriate capital levels to optimize ROAE, BVPS, and shareholder returns
- Consistent and robust approach to reserving, as evidenced through reserve releases every year since inception
Expanding our premium volume and capital base to capitalize on attractive
opportunities in a favorable market environment
4
|
Vision |
Building on our foundation |
|
of innovation, risk management, and industry expertise |
|
|
to create value for our shareholders, colleagues, and partners |
|
Brand |
||||||||||
|
Long-term capital |
Sustained risk- |
Leveraging |
Superior |
Proven risk & |
||||||
|
Differentiators |
||||||||||
|
custodians |
adjusted returns |
strategic |
underwriting |
capital |
||||||
|
over multiple |
partnerships |
discipline |
management |
|||||||
|
cycles |
||||||||||
Employee Values
AUTONOMY
Fidelis cultivates a culture of empowerment, accountability and self-direction within our organization. We foster an environment where individuals have the freedom to exercise their judgement, set ambitious goals, and work towards achieving them in ways that they deem most effective.
CONNECTED
We foster an inclusive and community orientated culture which recognizes that strength lies in unity and a shared sense of purpose among all stakeholders. We recognize that our purpose is to create tangible benefit for customers, shareholders and society at large, reflecting a commitment to ethical and socially responsible business practices.
EXPERT
Our company values expertise, encourages intellectual curiosity and fosters a dynamic environment where individuals can push boundaries to explore new possibilities. We cultivate a culture of creative thinking, experimentation with new ideas, and a willingness to embrace change to drive progress and innovation within our organization.
5
Strategic & Financial Overview
Why Invest in
|
High quality, |
Strong premium |
Proven track |
Robust capital |
Deep and highly |
|
mature, and well |
growth in |
record of |
position with a |
experienced |
|
positioned |
attractive lines |
delivering market- |
disciplined and |
leadership team |
|
specialty |
capitalizing on |
leading |
nimble approach |
with extensive |
|
insurance portfolio |
hard market |
combined ratios |
to capital |
underwriting, |
|
with historical |
conditions |
management, |
capital, and |
|
|
best-in-class |
including returning |
investment |
||
|
performance |
capital to |
management |
||
|
shareholders |
expertise |
High quality book of specialty insurance business that creates value through the
cycle by delivering consistent returns to shareholders
|
Note: |
7 |
- This slide contains forward looking statements covered by the PSLRA. See Safe Harbor Statement on Slide 2.
Long-Term Shareholder Value Creation Framework
Underwriting Profitability Investment Returns
|
Mid to High 80s%(1) |
4-5%(1) |
|
Combined Ratio |
Embedded portfolio |
|
yield + new money rate |
|
|
Operating ROAE |
|
|
13-15%(1) |
targeted through the cycle
Capital Management
- Allocating capital into attractive underwriting opportunities
- Constantly reassessing our outwards reinsurance purchasing
- Returning excess capital to shareholders through a combination of share buybacks and dividends
Maximizing value for shareholders by growing book value, generating consistent
returns, and optimizing capital management
|
Note: |
8 |
|
1) This slide contains forward looking statements covered by the PSLRA. See Safe Harbor Statement on Slide 2. |
A High Quality, Mature, and Well-Positioned Portfolio
Gross Premiums Written (for the 12 months ended
Over 100 products across our 10 major business classes
Other
SPECIALTY
- Scale position across traditional specialty lines
- 30 years+ of trading relationships
- Highly flexible approach
Property D&F 25%
Marine
19%Billion
Reinsurance
1%
REINSURANCE
• Focused property catastrophe
Propertybook
Reinsurance
17%• Sophisticated data and pricing capabilities
Other Bespoke 7%
BESPOKE
|
Aviation & |
Credit & Political |
|
|
Aerospace |
Risk |
|
|
10% |
Property |
12% |
|
Energy |
3% |
|
|
4% |
||
|
Specialty Other |
||
|
2% |
- Lead market across every deal with innovative coverage programs tailored to transaction facilitation
- Low attritional loss exposure
9
Driving Strong Premium and BVPS Growth
|
GPW ($bn) |
Book Value Per Diluted Common Share |
|
|
|
|
||
|
+27% |
+31% |
||
|
|
|||
|
|
|||
|
FY 2022 |
TTM Q1 2024(1) |
YE 2022(2) |
Q1 2024 |
Note:
- Gross Premiums Written trailing twelve months ("TTM") as of
March 31, 2024 .
|
2) As of the Separation Transactions on |
10 |
Attachments
Disclaimer



AM Best Affirms Credit Ratings of Tokio Marine Canada Ltd.
Chungnam National University Hospital Researchers Provide New Study Findings on Chronic Kidney Disease [The Factors Influencing Chronic Kidney Disease Incidence: Database from the Korean National Health Insurance Sharing Service (NHISS)]: Kidney Diseases and Conditions – Chronic Kidney Disease
Advisor News
- The best way to use a tax refund? Create a holistic plan
- CFP Board appoints K. Dane Snowden as CEO
- TIAA unveils ‘policy roadmap’ to boost retirement readiness
- 2026 may bring higher volatility, slower GDP growth, experts say
- Why affluent clients underuse advisor services and how to close the gap
More Advisor NewsAnnuity News
- Pinnacle Financial Services Launches New Agent Website, Elevating the Digital Experience for Independent Agents Nationwide
- Insurer Offers First Fixed Indexed Annuity with Bitcoin
- Assured Guaranty Enters Annuity Reinsurance Market
- Ameritas: FINRA settlement precludes new lawsuit over annuity sales
- Guaranty Income Life Marks 100th Anniversary
More Annuity NewsHealth/Employee Benefits News
- The Health Care Cost Curve Is Bending up Again
- Republicans can make healthcare affordable by focusing on insurance reforms
- Governor Stitt strengthens regulations for Medicare Advantage Plans
- Health insurance CEO can't commit to safe AI practices in Congressional hearing
- Harshbarger presses insurance CEOs on market control, vertical integration, conflict of interest
More Health/Employee Benefits NewsLife Insurance News